BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 7, 2007
View Archived Issues
Speedel, Novartis Gain FDA Approval Of Hypertension Drug
The FDA approved a new drug for high blood pressure, Tekturna (aliskiren), a first-in-class product partnered between Speedel Group and Novartis AG. (BioWorld Today)
Read More
InterMune Stopping Phase III IPF Program With Actimmune
Read More
Microbicide Research Advances Despite Recent Clinical Setbacks
Read More
BioCryst Getting $14M Up Front From Japanese Peramivir Partner
Read More
PainCeptor Brings In C$24.4M To Advance Pain Programs
Read More
Other News To Note
Read More
Clinic Roundup
Read More